Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • government

    Tag: government

    You Searched For "government"
    Should Next Gen DES Stents be removed from Price Cap- Govt Panel to Decide

    Should Next Gen DES Stents be removed from Price Cap- Govt Panel to Decide

    Farhat Nasim10 Aug 2019 4:51 PM IST
    NEW DELHI: In a bid to re-enter the market with advanced drug-eluting stents (DES), various medical device makers are in talks with the Government to...
    Price Cap: NLEM Committe to now target intraocular lens, dialysis fluid, hearing aids;

    Price Cap: NLEM Committe to now target intraocular lens, dialysis fluid, hearing aids;

    Farhat Nasim7 Aug 2019 5:30 PM IST
    New Delhi: After fixing the prices of various stents including cardiac stents and orthopaedic implants and even cancer drugs, the government is soon...
    Drug marketers as liable as Drug Manufacturers for quality, efficacy, regulatory compliance: Health Ministry Issues Draft

    Drug marketers as liable as Drug Manufacturers for quality, efficacy, regulatory compliance: Health Ministry Issues Draft

    Farhat Nasim28 Jun 2019 4:44 PM IST
    New Delhi: Through a recent draft Gazette notification, the Ministry of Health and Family Welfare has informed that not just drugmakers but drug...
    More than 10 percent of Drug samples from Government sources Not of Standard Quality

    More than 10 percent of Drug samples from Government sources Not of Standard Quality

    Meghna A Singhania25 Jun 2019 3:43 PM IST
    New Delhi: Estimated 10.02% medicines of the sample of medicines from government sources tested by the government were found to be Not of Standard...
    Its All In The Name: State drug regulators told to BAN marketing of new formulations in old brand names

    Its All In The Name: State drug regulators told to BAN marketing of new formulations in old brand names

    Farhat Nasim17 May 2019 5:37 PM IST
    New Delhi: In a major setback to many pharma companies in the country, the ruling Government is reported to have directed state drug controllers to...
    China war on healthcare costs lure Indian drugmaker Sun Pharma: Report

    China war on healthcare costs lure Indian drugmaker Sun Pharma: Report

    Medical Dialogues Bureau6 May 2019 9:15 AM IST
    China has rolled out an ambitious multi-city bulk procurement program that's driving down prices and providing an opening for Indian manufacturers...
    Supreme Court restrains Ministry of Health from taking a call on 15 banned FDC drugs

    Supreme Court restrains Ministry of Health from taking a call on 15 banned FDC drugs

    Ruby Khatun Khatun8 Sept 2018 6:13 PM IST
    The 15 FDCs include those of big brands like Abbott Healthcare's Phensydyl, Paras Pharmaceutical's D-Cold Tablet, Alkem's Sumo, Franco-Indian...
    Dabur sues government for denied tax sops under GST

    Dabur sues government for denied tax sops under GST

    Ruby Khatun Khatun23 Jun 2018 11:48 PM IST
    MUMBAI: Central and Uttarakhand government have been dragged to court by Dabur for rejecting tax sops for investment in poorer areas promised under...
    Cutting TB drugs prices in India: Johnson and Johnson, Mylan propose ways

    Cutting TB drugs prices in India: Johnson and Johnson, Mylan propose ways

    Ruby Khatun Khatun18 March 2018 3:51 PM IST
    New Delhi: To provide their Multidrug-Resistant (MDR) TB drugs at cheaper rates to TB patients in India so that patients could easily access to them...
    Allocate more funds, increase expenditure: Health experts

    Allocate more funds, increase expenditure: Health experts

    Ruby Khatun Khatun23 Jan 2018 10:00 AM IST
    New Delhi: With the Union Budget around the corner, two health experts have urged the government to allocate more funds to sectors such as family...
    Pharma giant Teva resists Israel PM on closure plan

    Pharma giant Teva resists Israel PM on closure plan

    Ruby Khatun Khatun21 Dec 2017 9:30 AM IST
    Jerusalem: Teva, the world's largest generic drug company, refused Tuesday to reconsider a decision to close its Jerusalem plant despite pressure from...
    1,179 Ayush drug manufacturers not compliant with Good Manufacturing Practices: Govt

    1,179 Ayush drug manufacturers not compliant with Good Manufacturing Practices: Govt

    Ruby Khatun Khatun20 Dec 2017 3:58 PM IST
    New Delhi: There are 8,667 licenced Ayurvedic, Siddha, Unani and Homoeopathy (ASU&H) drug manufacturers in the country, out of which 1,179 are...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok